H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.6% of adults in Amarillo have diagnosed diabetes — 1.6 points above the U.S. 12% figure. Census population 200,393. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Amarillo clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Amarillo storefront.
Skin Substitute Therapy Products in Amarillo, TX for clinics & physicians. Skin substitute therapy for com… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 25% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 13.6% of adults in Amarillo have diagnosed diabetes — 1.6 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. skin substitute therapy inventory is national; utilization is JH-local.
National Skin Substitute Therapy Products notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Amarillo we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 13.6% of adults in Amarillo have diagnosed diabetes — 1.6 points above the U.S. 12% figure.
If you already buy skin substitute therapy elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 13.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 13.6% of adults — 1.6 points above the U.S. 12% figure. Obesity is 38.5%; arthritis is 25%. That is place-level BRFSS modeling, not a clinic census and not a Amarillo trial.
No. They are B2B distribution pages for licensed providers. Patients in Amarillo should speak with their clinician, not use a distributor URL as care instructions.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Texas compliance risk.
Texas is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Amarillo tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Amarillo, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Amarillo is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Amarillo — 1.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Amarillo. Useful for joint-program math; still needs a diagnosis and privileging.
No Amarillo storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.